Assistance Publique Hopitaux De Paris

At Assistance Publique Hopitaux De Paris, the Rhumatologie department supports a strong portfolio in autoimmune and inflammatory diseases, with studies focused on conditions such as rheumatoid arthritis, ANCA-associated vasculitis, Sjögren's disease, and lupus nephritis. The research is largely aimed at improving symptom control, reducing disease activity, and finding better treatment strategies for patients with chronic immune-mediated illness.

• Testing new and targeted therapies for rheumatoid arthritis and related inflammatory joint disease
• Evaluating treatment approaches for vasculitis and other systemic autoimmune disorders
• Studying options to improve outcomes in lupus nephritis and Sjögren's syndrome

This area combines immune system research with practical efforts to improve long-term disease control and quality of life.

The site conducts extensive research in digestive system diseases, especially Crohn's disease, ulcerative colitis, and colorectal cancer. These trials are designed to assess new treatments, compare care strategies, and improve remission rates and recovery for people with chronic intestinal inflammation or digestive cancers.

• Studying therapies for Crohn's disease and ulcerative colitis
• Comparing treatment strategies for rectal cancer and other colorectal tumors
• Exploring ways to improve surgical and medical outcomes in digestive oncology

Research in this field at Assistance Publique Hopitaux De Paris emphasizes better control of inflammation, improved healing, and stronger cancer treatment results.

A major part of the research portfolio covers respiratory tract diseases and critical care, including pulmonary arterial hypertension, idiopathic pulmonary fibrosis, asthma, severe influenza, and pneumonia. These studies aim to improve breathing, reduce complications, and test new treatment options for both chronic and life-threatening lung conditions.

• Evaluating therapies for pulmonary hypertension and related vascular lung disease
• Testing treatments for asthma, pulmonary fibrosis, and other chronic lung disorders
• Studying care strategies in intensive care for severe respiratory infections and ventilation-related illness

This research reflects a broad effort to improve both long-term respiratory health and acute care outcomes.

The site has a strong focus on hemic and lymphatic diseases, especially hemophilia A, hemophilia B, von Willebrand disease, sickle cell disease, and immune thrombocytopenia. Many studies are designed to prevent bleeding, reduce transfusion needs, and improve safety in patients with inherited or acquired blood disorders.

• Assessing new approaches for hemophilia and other bleeding conditions
• Studying treatments to reduce pain and complications in sickle cell disease
• Exploring better management of thrombotic and hematologic complications

The work spans prevention, symptom relief, and long-term disease management across several complex blood disorders.

Clinical trials in nervous system diseases include multiple sclerosis, neuromyelitis optica spectrum disorder, chronic inflammatory demyelinating polyneuropathy, and myelin oligodendrocyte glycoprotein antibody-associated disease. The main goal is to improve relapse prevention, disability outcomes, and treatment selection for patients with autoimmune and inflammatory neurologic conditions.

• Testing therapies for demyelinating disease and autoimmune neuropathy
• Evaluating treatment timing and effectiveness in pediatric neuroimmunology
• Studying approaches to reduce relapses and preserve function in chronic neurologic disease

This field brings together neuroimmunology and pediatric care with a focus on better long-term outcomes.

The site also conducts important studies in cardiovascular diseases and vascular medicine, including heart failure, acute coronary syndrome, pulmonary embolism, and prevention of ischemic stroke. These trials are aimed at improving survival, lowering complication rates, and refining treatment choices for high-risk patients.

• Assessing treatments for heart failure and related cardiac conditions
• Studying prevention strategies after stroke or transient ischemic attack
• Evaluating care for pulmonary embolism and other vascular emergencies

Much of this work focuses on safer, more effective ways to reduce major cardiovascular events and improve recovery.

A notable portion of the portfolio covers hormonal diseases, genetic phenomena, and rare pediatric conditions such as growth hormone deficiency, short stature, congenital adrenal hyperplasia, and Cushing's disease. The studies are intended to improve growth, hormonal balance, and overall disease control in children and adults with uncommon endocrine disorders.

• Evaluating therapies for growth disorders in children
• Studying treatment options for rare endocrine diseases
• Exploring better management of genetic and hereditary conditions

At this European research site, rare disease studies help address conditions that often have limited treatment options.